Public Calendar: June 5-11, 2022
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs
Event Date: 06/06/2022
Location: Virtual
Subject: Regulatory Education for Industry 2022 Conference
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, and other registered participants
Event Date: 06/07/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Leadership and staff from health care provider groups
Event Date: 06/08/2022
Location: Virtual
Subject: "Next Legends" Youth Tobacco Prevention and Public Education Campaign Webinar
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, and other invited participants
Event Date: 06/08/2022
Location: Washington, DC
Subject: Johnson and Johnson Innovation: The Role of FDA in Driving Inclusive Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other invited guests
Event Date: 06/08/2022
Location: Virtual
Subject: Overview of Operations and Partnership with American Red Cross
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Chris Hrouda, Gail McGovern (American Red Cross);
Event Date: 06/09/2022
Location: Virtual
Subject: FDA Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Health Care Leadership Council and Staff
Event Date: 06/10/2022
Location: Virtual
Subject: FDA's Food Program and Food Priorities for the Future
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several leaders and staff from Sustainable Food Policy Alliance
Event Date: 06/10/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several industry groups interested in infant formula issues
Event Date: 06/10/2022
Location: Virtual
Subject: Introductions and FDA Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Donald Hoppert, Georges Benjamin, James Carbo, Jordan Wolfe, Susan Polan (American Public Health Association);
Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner
Event Date: 06/06/2022
Location: Virtual
Subject: Researching COVID to Enhance Recovery (RECOVER) Executive Committee Meeting
FDA Participant/Group: Peter Marks
Non FDA Participant/Group: Executive committee members of RECOVER
Event Date: 06/07/2022
Location: Washington, DC
Subject: 8th Annual FedHealthIT Innovation Conference and Award Ceremony; Keynote Speaker
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, and other stakeholders
Event Date: 06/09/2022
Location: Virtual
Subject: TransCelerate Roundtable; Panelist: Community-Based Site Engagement and Capacity Building
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders
Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 06/08/2022
Location: Virtual
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff from the U.S. Senate Committee on Health, Education, Labor and Pensions
Event Date: 06/08/2022
Location: Virtual
Subject: World Health Organization Meeting; Panelist: Digitalization, Food Safety and Trade - A Regulator's Perspective
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from foreign government agencies, academia, and food industry
Event Date: 06/09/2022
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from across the consumer associations, and scientific and technical staff from industry
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
Event Date: 06/06/2022
Location: Virtual
Subject: Summit of the Americas; Speaker: Remarks to the Inter-American Coalition Session for Regulatory Convergence Pre-Conference Forum
FDA Participant/Group: N/A
Non FDA Participant/Group: Inter-American Coalition for Regulatory Convergence
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Erica Jefferson, Associate Commissioner for External Affairs
No Significant Event
Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
Event Date: 06/09/2022
Location: Virtual
Subject: National Organization for Rare Disorders (NORD) Corporate Council Meeting
FDA Participant/Group: KERRY LEE;
Non FDA Participant/Group: Alexa Moore, Carrie Lucas (National Organization for Rare Disorders (NORD));
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 06/06/2022
Location: Virtual
Subject: Regulatory Education for Industry Annual Conference 2022; Plenary Session - COVID-19: What's Next for FDA?
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of Regulatory Education for Industry Annual Conference 2022
Event Date: 06/07/2022
Location: Virtual
Subject: Vaccine and Related Biological Products (VRBPAC) Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of Vaccine and Related Biological Products (VRBPAC) Meeting
Event Date: 06/07/2022
Location: Virtual
Subject: 2022 Virtual Regenerative Medicine Essentials Course and World Stem Cell Summit; Session 6: Regulatory, Process Development and Manufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of 2022 Virtual Regenerative Medicine Essentials Course and World Stem Cell Summit
Event Date: 06/08/2022
Location: Virtual
Subject: California Separation Science Society (CASSS) Meeting; Keynote on Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of California Separation Science Society (CASSS) Meeting
Event Date: 06/08/2022
Location: Virtual
Subject: Allogeneic Accelerated Development Network (AADN) Meeting; Town Hall Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of Allogeneic Accelerated Development Network (AADN) Meeting
Event Date: 06/09/2022
Location: Virtual
Subject: Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) Meeting
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 06/08/2022
Location: Washington, DC
Subject: Consumer Technology Association (CTA) Health Industry Leaders Summit; Speaker: CDRH Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Michele Mital, Acting Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event